Financial Data and Key Metrics Changes - Revenue for Q3 2025 was $153 million, up 7% year over year, with EPS of $0.33, an increase of 22% year over year, and cash from operations at $29 million, all exceeding the midpoint of guidance [5][13][19] - Gross margins for Q3 were 53%, flat compared to the previous year, with expectations to remain above 50% for the full year 2025 [14][19] Business Line Data and Key Metrics Changes - MedTech and Specialty Audio segment revenue was $65 million, up 2% year over year, driven by increased demand in the specialty audio market [5][13] - Precision Devices segment revenue was $88 million, up 12% year over year, with strong growth across all end markets including medtech, defense, industrial, and EV [6][14] Market Data and Key Metrics Changes - The defense market showed particularly strong performance, with design wins and bookings outpacing other end markets [8][9] - Bookings in the Precision Devices segment remained strong, particularly in defense and with distribution partners, indicating normalized channel inventories [9][44] Company Strategy and Development Direction - The company is focused on leveraging unique technologies to design custom engineered solutions and deliver them at scale, positioning itself well for future growth [4][10] - The strategy includes expanding specialty film production and pursuing synergistic acquisitions while maintaining manageable debt levels [11][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in entering a period of accelerated organic growth, supported by strong design wins and a healthy backlog of orders [10][12] - The company expects organic growth rates at the high end of the stated range of 4% to 6% for the total company in 2025, driven by robust secular growth trends [10][19] Other Important Information - Cash generation from operations was robust, allowing for share repurchases of $20 million and a reduction in bank borrowings by $15 million [11][16] - The company has a strong balance sheet with liquidity exceeding $350 million, and exposure to tariffs is less than 5% of revenue [17][18] Q&A Session Summary Question: Specialty film capacity and demand outlook - Management indicated that specialty film revenue is expected to be in the range of $55 million to $60 million next year, with a backlog of $25 million to $30 million [21][23] Question: Design activity and growth expectations - Management expects MedTech and Specialty Audio growth in the range of 2% to 4%, while Precision Devices may exceed the high end of the 6% to 8% growth range [25][26] Question: Specialty film applications and follow-up orders - Specialty film is focused on pulse power applications, with emerging applications in defibrillators and radiotherapy, indicating strong future demand [32][33] Question: M&A environment and strategy - The company remains focused on acquisitions but is being disciplined, ensuring any acquisition makes strategic sense [37][38] Question: Book to bill ratio and palladium prices - The book to bill ratio for the Precision Devices segment was one for the quarter, with strong bookings and a high backlog [44] - Palladium prices have increased, but the company has pre-buys in place to mitigate impact on gross margins [41][42]